MS and Natalizumab: 3 New Findings

Slideshow

Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.

Natalizumab is a highly effective therapy for relapsing-remitting multiple sclerosis. However, its efficacy in the context of other more recently available treatments needs to be assessed. Further, hampering the long-term of use of natalizumab is the association of treatment with a risk of progressive multifocal leukoencephalopathy (PML).The slides above highlight findings of 3 new studies of natalizumab.   

Related Videos
Marjan Gharagozloo, PhD
 Jeffrey Huang, PhD
Shiv Saidha, MBBCh
Julie Fiol, MSCN; Andreina Barnola, MD, MPH
Lars Alfredsson, PhD
Jenn Orthmann-Murphy, MD, PhD
Amit Bar-Or, MD, FRCPC, FAAN, FANA
Jason Freeman, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.